Year: 2026
Type: article
Abstract: Artificial Intelligence (AI) has emerged as a transformative force in pharmaceutical sciences, particularly in drug discovery and development. Traditional drug development is a lengthy, expensive, and failure-prone process. AI technologies including machine learning, deep learning, and natural language processing enable efficient analysis of large biological datasets, accelerating target identification, lead optimization, and clinical decision-making. AI-driven platforms have demonstrated significant success in reducing time and cost while improving accuracy. This review highlights the current status of AI applications across various stages of drug discovery and development, discusses key technological advancements, and evaluates challenges such as data quality, regulatory barriers, and ethical concerns. Furthermore, future perspectives including integration with quantum computing, digital twins, and personalized medicine are explored. AI is poised to revolutionize the pharmaceutical landscape by enabling faster, safer, and more effective therapeutic development.
Language: English
Subfield: Drug Discovery
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W7163736680
